David Young, President of Processa Pharmaceuticals PCSA, has filed 14 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $27.5K. The latest trade was on 06/15.

DY

DY

David Young

Pres. Research & Development

Company

Processa Pharmaceuticals PCSA

First filing

23/01/04

Trades

39 trades

Buys / sales

14 / 0

12-month net buying

$27.5K

Last trade

06/15

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Processa PharmaceuticalsPCSA	Open-market buy	06/15	06/16	2,067 sh	$2.22	$4,588.74	+12.1%
Processa PharmaceuticalsPCSA	Open-market buy	05/29	06/01	1,786 sh	$2.57	$4,590.02	+11.6%
Processa PharmaceuticalsPCSA	Open-market buy	05/15	05/19	1,545 sh	$2.97	$4,588.65	+11.2%
Processa PharmaceuticalsPCSA	Open-market buy	04/30	05/01	1,706 sh	$2.69	$4,589.14	+14.1%
Processa PharmaceuticalsPCSA	Open-market buy	04/15	04/17	1,545 sh	$2.97	$4,588.65	+14.6%
Processa PharmaceuticalsPCSA	Open-market buy	03/31	04/01	1,810 sh	$2.54	$4,597.4	+20.7%
Processa PharmaceuticalsPCSA	Open-market buy	25/01/27	25/01/29	124,500 sh	$0.80	$99,600	+153.9%
Processa PharmaceuticalsPCSA	Open-market buy	24/02/07	24/02/08	21,000 sh	$2.45	$51,450	+36.0%
Processa PharmaceuticalsPCSA	Open-market buy	24/02/06	24/02/07	20,000 sh	$2.53	$50,600	+52.1%
Processa PharmaceuticalsPCSA	Open-market buy	23/06/12	23/06/12	40,000 sh	$0.80	$32,000	+9.3%
Processa PharmaceuticalsPCSA	Open-market buy	23/04/14	23/04/14	20,000 sh	$0.55	$11,000	+4.9%
Processa PharmaceuticalsPCSA	Open-market buy	23/04/11–23/04/13	23/04/13	60,000 sh3 trades	$0.48avg.	$29,000	+17.1%